Comparative efficacy and safety of reperfusion therapy with fibrinolytic agents in patients with ST-segment elevation myocardial infarction: a systematic review and network meta-analysis
- 1 August 2017
- journal article
- review article
- Published by Elsevier in The Lancet
- Vol. 390 (10096) , 747-759
Abstract
No abstract availableKeywords
This publication has 71 references indexed in Scilit:
- Graphical Tools for Network Meta-Analysis in STATAPLOS ONE, 2013
- Reperfusion therapy for STEMI: is there still a role for thrombolysis in the era of primary percutaneous coronary intervention?The Lancet, 2013
- Management of acute coronary syndromes in developing countries: ACute Coronary Events—a multinational Survey of current management StrategiesAmerican Heart Journal, 2011
- The Cochrane Collaboration's tool for assessing risk of bias in randomised trialsBMJ, 2011
- Combination of direct and indirect evidence in mixed treatment comparisonsStatistics in Medicine, 2004
- Measuring inconsistency in meta-analysesBMJ, 2003
- Effect of Intravenous Streptokinase as Compared with That of Tissue Plasminogen Activator on Left Ventricular Function after First Myocardial InfarctionNew England Journal of Medicine, 1989
- Effect of Intravenous Streptokinase on Left Ventricular Function and Early Survival after Acute Myocardial InfarctionNew England Journal of Medicine, 1987
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986
- A Prospective Trial of Intravenous Streptokinase in Acute Myocardial Infarction (I.S.A.M.)New England Journal of Medicine, 1986